Dec 22, 2024, 17:36
Nicholas Hornstein: Something new in BRAF V600E mCRC
Nicholas Hornstein, Assistant Professor of Medical Oncology at Northwell Health, posted on X:
“Something new in BRAF V600E mCRC!
encorafenib (enco) + cetuximab (cet) + FOLFOX.
Nice increase in ORR (61% vs 40%)
~ 3 month increase in PFS (14 vs 11 months)
AEs likely will dictate uptake.
Ready for prime time?
Huge progress in the disease by Scott Kopetz.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 22, 2024, 17:36
Dec 22, 2024, 17:32
Dec 22, 2024, 17:18
Dec 22, 2024, 16:46